Metabolite characterization of a novel anti-cancer agent, icotinib, in humans through liquid chromatography/quadrupole time-of-flight tandem mass spectrometry.

Rapid communications in mass spectrometry : RCM

Volumn 25, Issue 15, 2011, Pages 2131-2140

  Liu, Dongyang ^a   Jiang, J ^b   Zhang, L ^b   Tan, Fenlai ^b   Wang, Yingxiang ^b   Hu, Pei ^b  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CROWN ETHER; ICOTINIB; QUINAZOLINE DERIVATIVE;

ADULT; ANIMAL; ARTICLE; BLOOD; CHEMISTRY; FECES; HUMAN; LIQUID CHROMATOGRAPHY; MALE; METABOLISM; METHODOLOGY; RAT; TANDEM MASS SPECTROMETRY; URINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, LIQUID; CROWN ETHERS; FECES; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; QUINAZOLINES; RATS; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 80052794272     PISSN: None     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.5061     Document Type: Article

References (0)